PT Kalbe Farma Tbk
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTKFY research report →
Price Chart
About the company
PT Kalbe Farma Tbk. , an Indonesian pharmaceutical leader, along with its subsidiaries, focuses on the development, manufacturing, and commercialization of pharmaceutical products across Indonesia. Its operations are structured into four primary divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics.
- CEO
- Bernadette Ruth Irawati Setiady
- IPO
- 2012
- Employees
- 12,835
- HQ
- Jakarta, JK, ID
Get TickerSpark's AI analysis on PTKFY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.89B
- P/E
- 9.37
- PEG
- 1.10
- P/S
- 0.92
- P/B
- 1.40
- EV/EBITDA
- 5.45
- Div Yield
- 2.56%
- Gross Margin
- 37.18%
- Op Margin
- 12.25%
- Net Margin
- 9.84%
- ROE
- 15.54%
- ROIC
- 13.47%
Latest fiscal year · YoY change
- Revenue
- $35.32T+8.3%
- Gross Profit
- $14.06T+8.5%
- Op Income
- $4.55T
- Net Income
- $3.66T+13.1%
- EPS
- $16176.00+15.3%
- OCF Growth
- -31.7%
- FCF Growth
- -30.4%
- 52W High
- $16.11
- 52W Low
- $7.21
- 50D MA
- $8.22
- 200D MA
- $9.67
- Beta
- 0.05
- RSI (14)
- 57
- Avg Volume
- 989
No earnings-call transcripts are available for PTKFY yet.
- Free Float
- 39.7%
- Shares Outstanding
- 225.97M
- Float Shares
- 89.65M
Our PTKFY coverage
Recent articles, reports, and earnings notes.
No research on PTKFY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PTKFY report →